Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells

被引:40
作者
Gueret, V [1 ]
Negrete-Virgen, JA [1 ]
Lyddiatt, A [1 ]
Al-Rubeai, M [1 ]
机构
[1] Univ Birmingham, Dept Chem Engn, Birmingham B15 2TT, W Midlands, England
关键词
adenovirus titration; adenoviral vectors; flow cytometry; GFP; infectivity;
D O I
10.1023/A:1021106116887
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There is a constant and growing interest in exploiting adenoviruses as vectors for gene therapy when transient expression of a therapeutic protein is necessary. The requirement for an increased viral titre has prompted a search for techniques by which this virus may be assayed with greater speed and simplicity. Conventional plaque assay for quantification of adenoviral vectors titre in current use is laborious and time-consuming (up to 14 days). We report herein a method for the monitoring of adenovirus expressing green fluorescent protein that incorporates rapid and easy sample handling by means of flow cytometric analysis. Cells (HEK293) were infected with adenovirus at various multiplicity of infection (MOI), harvested 17 to 20 h post infection and analysed by flow cytometry. Assumptions were made that one fluorescent cell was infected by a single infectious particle at a relatively low MOI. The adenoviral titre was subsequently estimated from cell analysis in a relatively short time. The results obtained with an E1-complementing cell line (HEK293) were compared with that obtained using a non-complementing cell line (A549). A Poisson distribution successfully modelled the profile of infection as a function of MOI. This provided a better understanding of adenoviral infection at the earliest stage possible. Monitoring of GFP fluorescence and virus propagation in a batch culture of infected cells was subsequently used as a practical application of the validated method.
引用
收藏
页码:87 / 97
页数:11
相关论文
共 24 条
  • [1] An improved anion-exchange HPLC method for the detection and purification of adenoviral particles
    Blanche, F
    Cameron, B
    Barbot, A
    Ferrero, L
    Guillemin, T
    Guyot, S
    Somarriba, S
    Bisch, D
    [J]. GENE THERAPY, 2000, 7 (12) : 1055 - 1062
  • [2] COOPER P. D., 1961, ADVANCES IN VIRUS RES, V8, P319
  • [3] Study of adenovirus production in serum-free 293SF suspension culture by GFP-expression monitoring
    Cote, J
    Bourget, L
    Garnier, A
    Kamen, A
    [J]. BIOTECHNOLOGY PROGRESS, 1997, 13 (06) : 709 - 714
  • [4] Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry
    Domínguez, J
    Lorenzo, MD
    Blasco, R
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 220 (1-2) : 115 - 121
  • [5] Direct imaging of Northern blots on an optical scanner using ethidium bromide
    Eykholt, RL
    Mitchell, MD
    Marvin, KW
    [J]. BIOTECHNIQUES, 2000, 28 (05) : 864 - +
  • [6] Galbraith DW, 1999, METHOD CELL BIOL, V58, P315
  • [7] Gene therapy
    Kay, MA
    Liu, DX
    Hoogerbrugge, PM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 12744 - 12746
  • [8] LURIA SE, 1978, GEN VIROLOGY, P21
  • [9] POLYPEPTIDES OF ADENOVIRUS .I. EVIDENCE FOR MULTIPLE PROTEIN COMPONENTS IN VIRION AND A COMPARISON OF TYPES 2 7A AND 12
    MAIZEL, JV
    WHITE, DO
    SCHARFF, MD
    [J]. VIROLOGY, 1968, 36 (01) : 115 - +
  • [10] PHARMACOKINETICS OF ADENOVIRAL VECTOR-MEDIATED GENE DELIVERY TO VASCULAR SMOOTH-MUSCLE CELLS - MODULATION BY POLOXAMER-407 AND IMPLICATIONS FOR CARDIOVASCULAR GENE-THERAPY
    MARCH, KL
    MADISON, JE
    TRAPNELL, BC
    [J]. HUMAN GENE THERAPY, 1995, 6 (01) : 41 - 53